BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation

Bristol Myers Squibb (BMS) has filed a lawsuit against the Biden administration, following in Merck's footsteps, claiming that an upcoming Medicare drug negotiation program violates the First and Fifth Amendments of the U.S. Constitution. The company alleges that if the drug price negotiation program comes into force, it would force pharma companies to give big discounts to Medicare and sell the..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 20.
  • textsms

Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement

Pharmaceutical companies and pharmacies have agreed to pay $19 billion in an opioid settlement with state and local governments, settling lawsuits alleging that Allergan, Teva Pharmaceuticals, CVS, Walgreens, and Walmart drove the opioid epidemic. The settlement comes after AbbVie (through Allergan) and Teva were set to pay some $5 billion to settle about 3,500 opioid lawsuits more than a year a..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 13.
  • textsms